|
Market Closed -
Nasdaq
02:30:00 14/11/2026 am IST
|
5-day change | 1st Jan Change | ||
| 16.14 USD | +1.70% |
|
+7.10% | +4.60% |
| 13/11 | Jade Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026 | CI |
| 13/11 | Jade Biosciences Q3 Net Loss Narrows | MT |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| JBIO | Delayed | |
| JBIO | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bearish | Neutral |
| Resistance | 16.54 | 19.15 | 25.81 |
| Spread/Res. | -2.42% | -15.72% | -37.47% |
| Spread/Supp. | +6.68% | +20.36% | +20.54% |
| Support | 15.13 | 13.41 | 13.39 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- JBIO Stock
- Charts Jade Biosciences, Inc.
Select your edition
All financial news and data tailored to specific country editions
















